{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:17:15Z","timestamp":1769354235783,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.amjcard.2006.02.017","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T12:14:41Z","timestamp":1143807281000},"page":"3-9","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S1","title":["Clinical Implications of Nonopioid Analgesia for Relief of Mild-to-Moderate Pain in Patients with or at Risk for Cardiovascular Disease"],"prefix":"10.1016","volume":"97","author":[{"given":"Andrew","family":"Whelton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2006.02.017_bib1","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjcard.2006.02.017_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0272-6386(96)90046-3","article-title":"Analgesics and the kidney","volume":"27","author":"Henrich","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"suppl 3A","key":"10.1016\/j.amjcard.2006.02.017_bib3","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(00)00699-9","article-title":"Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors","volume":"110","author":"Whelton","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1552-4604.1991.tb03743.x","article-title":"Nonsteroidal anti-inflammatory drugs","volume":"31","author":"Whelton","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2006.02.017_bib5","first-page":"39","article-title":"Nonsteroidal anti-inflammatory drugs","volume":"155","author":"Bush","year":"1991","journal-title":"West J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib7","series-title":"Effects of nonsteroidal anti-inflammatory drugs and COX-2 inhibitors on aspirin-induced platelet inhibition","author":"Dong","year":"2004"},{"issue":"suppl","key":"10.1016\/j.amjcard.2006.02.017_bib8","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1016\/S0002-9343(99)00369-1","article-title":"Effects of nonsteroidal anti-inflammatory drugs on renal function","volume":"107","author":"Brater","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198402023100502","article-title":"Effects of sulindac and ibuprofen in patients with chronic glomerular disease","volume":"310","author":"Ciabattoni","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archinte.1996.00440130066007","article-title":"Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis","volume":"156","author":"Singh","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.amjcard.2006.02.017_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/367243a0","article-title":"The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1","volume":"367","author":"Picot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.amjcard.2006.02.017_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00124743-199606000-00005","article-title":"Nonsteroidal antiinflammatory drugs and their effects","volume":"2","author":"Simon","year":"1996","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.amjcard.2006.02.017_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198809153191106","article-title":"Clinical implications of prostaglandin and thromboxane A2 formation (first of two parts)","volume":"319","author":"Oates","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM198809223191206","article-title":"Clinical implications of prostaglandin and thromboxane A2 formation (second of two parts)","volume":"319","author":"Oates","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)38195-9","article-title":"Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids","volume":"289","author":"Catella-Lawson","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjcard.2006.02.017_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/archinte.160.10.1465","article-title":"Effects of celecoxib and naproxen on renal function in the elderly","volume":"160","author":"Whelton","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","article-title":"Mechanism of action of paracetamol","volume":"12","author":"Graham","year":"2005","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2006.02.017_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","article-title":"The clinical significance of inhibition of renal prostaglandin synthesis","volume":"32","author":"Patrono","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjcard.2006.02.017_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjcard.2006.02.017_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/08860229909045192","article-title":"Acute effects of acetaminophen on renal function and urinary excretion of some proteins and enzymes in patients with kidney disease","volume":"21","author":"Mitic-Zlatkovic","year":"1999","journal-title":"Ren Fail"},{"key":"10.1016\/j.amjcard.2006.02.017_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.1994.03520100043031","article-title":"Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy","volume":"272","author":"Gurwitz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.017_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"Johnson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9149(02)02661-9","article-title":"Effects of celecoxib and rofecoxib on blood pressure and edema in patients \u226565 years of age with systemic hypertension and osteoarthritis","volume":"90","author":"Whelton","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.017_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00045391-200103000-00003","article-title":"Cyclooxygenase-2-specific inhibitors and cardiorenal function","volume":"8","author":"Whelton","year":"2001","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2006.02.017_bib29","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.017_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"MRC trial of treatment of mild hypertension","volume":"291","year":"1985","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2006.02.017_bib31","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.017_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.02.017_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"suppl 5A","key":"10.1016\/j.amjcard.2006.02.017_bib34","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/0002-9343(91)90485-G","article-title":"Nonsteroidal anti-inflammatory drugs and antihypertensives","volume":"90","author":"Houston","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0149-2918(98)80049-0","article-title":"The impact of nonsteroidal anti-inflammatory drugs on hypertension","volume":"20","author":"Ruoff","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2006.02.017_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000186173","article-title":"Nonsteroidal anti-inflammatory drugs and antihypertensives","volume":"56","author":"Sahloul","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.amjcard.2006.02.017_bib37","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib38","first-page":"22","article-title":"Effect of pain and nonsteroidal analgesics on blood pressure","volume":"98","author":"Chawla","year":"1999","journal-title":"WMJ"},{"key":"10.1016\/j.amjcard.2006.02.017_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2165\/00002018-199717030-00003","article-title":"Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure","volume":"17","author":"Feenstra","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjcard.2006.02.017_bib40","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.158.10.1108","article-title":"NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics","volume":"158","author":"Heerdink","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAIDs and the development of congestive heart failure in elderly patients","volume":"160","author":"Page","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002280100266","article-title":"Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population","volume":"57","author":"Merlo","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2006.02.017_bib43","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.1996.00440200041005","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure","volume":"156","author":"Guttham","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2006.02.017_bib44","first-page":"55","article-title":"Patterns of tubulo-interstitial damage associated with nonsteroidal antiinflammatory drugs","volume":"8","author":"Levin","year":"1988","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.amjcard.2006.02.017_bib45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-112-8-568","article-title":"Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure","volume":"112","author":"Whelton","year":"1990","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906002153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906002153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:55:20Z","timestamp":1736315720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906002153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0002914906002153"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2006.02.017","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}